Chester County News and Community Website
WILMINGTON, DE — AstraZeneca has secured U.S. regulatory approval for IMFINZI (durvalumab) in combination with Bacillus Calmette-Guérin (BCG) therapy for adults with previously untreated high-risk non-muscle-invasive bladder cancer, expanding the …
AstraZeneca Wins FDA Approval for IMFINZI in Early Bladder Cancer Read More
PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network has launched a free weekly email service that alerts users to changes in its widely used cancer treatment guidelines, expanding access …
NCCN Launches Weekly Cancer Guideline Alerts for Clinicians Read More WILMINGTON, DE — AstraZeneca said new Phase III cancer and rare disease data presented at the American Society of Clinical Oncology annual meeting could strengthen the company’s position in several …
AstraZeneca Highlights Late-Stage Cancer, Rare Disease Data at ASCO Read More
WILMINGTON, DE — AstraZeneca (LSE/STO/NYSE: AZN) reported positive Phase III trial results showing its immunotherapy IMFINZI combined with enfortumab vedotin improved survival outcomes for certain muscle-invasive bladder cancer patients unable …
AstraZeneca Trial Extends Survival in Bladder Cancer Study Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has approved Bizengri for adults with advanced NRG1 fusion-positive cholangiocarcinoma, marking the first approved treatment for the rare bile duct cancer …
FDA Approves Bizengri for Rare Bile Duct Cancer Read More
PHILADELPHIA, PA — Dispatch Bio said it will present new preclinical data on its SEND T cell engineering platform at the ASGCT 2026 Annual Meeting, highlighting experimental results showing anti-tumor …
Dispatch Bio Reports Preclinical Cancer Therapy Data Read More
HARRISBURG, PA — A $450 million investment to build a new pharmaceutical manufacturing facility in Philadelphia is expected to create 225 jobs and expand the production of materials used in …
$450M Pharma Plant to Bring Jobs, Cancer Research to Philly Read More
WILMINGTON, DE — The European Commission has approved Zynyz (retifanlimab), developed by Incyte (Nasdaq: INCY), in combination with carboplatin and paclitaxel for the first-line treatment of adults with metastatic or …
Incyte Drug Zynyz Approved in Europe for Anal Canal Cancer Treatment Read More
What This Means for You More than 500 new jobs are expected in Montgomery County over the next 12 years. The state will provide up to $41.5 million in financial …
Johnson & Johnson to Invest $1 Billion in Montgomery County Cancer Drug Facility Read More PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network, on World Cancer Day, observed February 4, highlighted its free patient guidelines aimed at helping people navigate a cancer diagnosis, according …
NCCN Highlights Free Patient Cancer Guidelines on World Cancer Day Read More